News.

Press releases and featured media

In the Media 2 mins
June 05, 2023

The Path to Automation in the Clinical Laboratory

As clinical labs face a slew of workflow challenges—including personnel shortages and increasing pressure to reduce costs—automation is making a strong case for adoption. This technology’s affinity for completing otherwise tedious, repetitive tasks means that lab technologists and clinicians can spend more time making critical and better-informed decisions, some of which may lead to life-changing and life-saving results for patients.
Link to full article
In the Media 2 mins
June 10, 2022

High Throughput Hematological Analysis Platform Receives FDA Clearance

Scopio Labs announced that its X100HT device with Peripheral Blood Smear (PBS) Application has received U.S. FDA 510(k) clearance. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.
Link to full article
Press Releases 4 mins
June 09, 2022

Scopio Labs Awarded FDA Clearance for High Throughput Hematology Digital Cell Morphology Platform, Replacing Microscopes with Digitization

This is the company's second FDA clearance, broadening its suite of fully digital platforms to cater to all lab sizes and networks. Coupling high throughput capabilities with the highest resolution for hematological analysis, the X100HT caters to major medical facilities and labs across the world.
Read more
In the Media 3 mins
June 09, 2022

AI-powered scope developer says new FDA clearance opens the door for telehematology

Scopio Labs today announced FDA 510(k) clearance for its X100HT, which features a new slide loader that automatically prepares samples and feeds them into the digital blood scanner for AI-powered analysis. The Tel Aviv-based digital microscope developer said the technology eliminates the need for manual microscopic examination when reviewing white and red blood cells and estimating platelet counts.
Link to full article
In the Media 6 mins
May 26, 2022

Digital Microscope Streamlines The Search For Cell Abnormalities In Blood

Microscopes can see what is invisible to the naked eye. For this reason, and many others, they are essential for scientists who aim the learn more about the way the human body operates by studying those minuscule building blocks called cells.
Link to full article
Press Releases 4 mins
February 09, 2022

Scopio raises $50M to take a deeper look into our blood cells

Scopio Labs, provider of the world’s first full-field digital cell morphology solution, today announced a $50M investment for its end-to-end hardware and software platform for digitizing, quantifying and analyzing hematology and other digital cytology samples. The Series C round included OurCrowd, Aurum Ventures, Mizrahi-Tefahot Bank Invest and Ilex Medical, with the participation of strategic investors operating in the field and existing investors.
Read more
In the Media 2 mins
February 09, 2022

Digital blood test co Scopio Labs raises $50m

The company’s ultra-high quality and FDA-cleared imaging and AI analysis platforms enhance diagnostic capabilities and enable remote work.
Link to full article
In the Media 5 mins
February 09, 2022

Scopio aims to turn hematology into remote work with $50M C round

Today, if a hematologist wanted to dive into the exact organization and structure of your blood cells, they’d probably need a microscope in a lab. Scopio, an Israel-based startup that just closed a $50 million Series C round, argues that soon, a lot of that work could be done with nothing more than a laptop.
Link to full article
Press Releases 4 mins
September 27, 2021

Scopio Labs Launches Full-Field Peripheral Blood Smear Application, Bringing End-to-End Digital Workflow to Hematology Labs to Transform Diagnostic Testing

Scopio Labs, provider of the world’s first full-field digital cell morphology solution, announced today the commercial launch of its FDA-cleared and CE-approved Full-Field Peripheral Blood Smear (FF-PBS) Application on the X100 platform. The application’s commercialization is an important step in the company’s plan to transform hematology and introduce a new line of digital solutions for cell morphology analysis that enable earlier detection, diagnosis and treatment for improved patient outcomes.
Read more
In the Media 1 min
September 26, 2021

Scopio introduces full-field PBS application

Scopio Labs has formally launched its full-field peripheral blood smear (PBS) application on the firm's X100 platform. The application combines full-field imaging and an artificial intelligence-based decisions-support system with remote capabilities.
Link to full article

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo